Industry Workshop by GE HealthCare

IWS 79 - Diagnostic performance of Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of hepatic steatosis in patients with biopsy-proven non-alcoholic fatty liver disease: a prospective study

March 2, 11:15 - 12:00 CET

Industry Workshop by GE HealthCare
Tommaso Vincenzo Bartolotta, None / Italy
In this workshop, Prof Tommaso Bartolotta will share the results of the prospective study conducted at his Institute to validate the accuracy of UGAP, non-invasive technique, to stage liver steatosis in comparison to biopsy. The format of the session will favour an open discussion and live hands on.
Sign up here